Well Health Technologies Corp. (T:WELL*CA)
Business Focus: Healthcare Facilities & Services (NEC)
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| Company Contact | |
| Address: | Suite 550 - 375 Water Street VANCOUVER BC V6B 5C6 |
| Tel: | 1-604-6287266 |
| Website: | https://www.well.company |
| IR: | See website |
| Key People | ||
| Hamed Shahbazi Executive Chairman of the Board, Chief Executive Officer | Eva Fong Chief Financial Officer | Jay Kreger Chief Executive Officer of CRH Medical Corporation |
| Amir Javidan Chief Operating Officer | Beemal Shahl Chief Operating Officer of CRH Medical Corporation | |
| Business Overview |
| WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare's in Canada with 165 clinics supporting primary care, specialized care and diagnostic services. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, WELL Health Technologies Corp revenues increased 36% to C$776.1M. Net income decreased 94% to C$82K. Revenues reflect Primary segment increase of 69% to C$119.1M, United States (Country) segment increase of 44% to C$476.9M, Canada (Country) segment increase of 25% to C$299.1M. Net income was offset by Time-based earnout (expense) recovery increase from C$15.8M (income) to C$21.4M (expense). |
| Employees: | 1,710 as of Dec 31, 2022 |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $1,236M as of Dec 31, 2023 |
| Annual revenue (TTM): | $776.05M as of Dec 31, 2023 |
| EBITDA (TTM): | $101.88M as of Dec 31, 2023 |
| Net annual income (TTM): | $0.08M as of Dec 31, 2023 |
| Free cash flow (TTM): | $57.63M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $382.86M as of Dec 31, 2023 |
| Shares outstanding: | 242,831,580 as of Mar 27, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.